Inaccurate MDS Medication Coding for a Resident
Summary
The facility failed to ensure that a resident's Minimum Data Set (MDS) assessment accurately reflected the medications administered during the assessment period. Specifically, the MDS for one resident did not indicate the use of an anticonvulsant (Gabapentin) or a hypoglycemic medication (Ozempic), despite both being prescribed and administered as documented in the resident's medical records and Medication Administration Record (MAR). The resident had diagnoses including Type 2 diabetes and multiple sclerosis, and was receiving Gabapentin for insomnia and Ozempic for diabetes management. Interviews with facility staff revealed that the MDS Coordinator was responsible for coding the MDS assessments and care plans. The MDS Coordinator acknowledged coding Ozempic as an injection but was unsure if it should also be coded as a hypoglycemic medication. She also associated Gabapentin with nerve pain rather than its pharmacological classification as an anticonvulsant, despite recognizing that the MDS should be coded by drug class. The Director of Nursing (DON), Administrator, and Corporate MDS Coordinator all confirmed that the medications should have been coded according to their pharmacological classifications on the MDS. The facility's policy requires that MDS assessments be completed and coded per the Resident Assessment Instrument (RAI) manual, based on clinical assessments and interventions. The failure to accurately code the resident's medications on the MDS assessment was confirmed through record review and staff interviews, indicating a lapse in following established procedures for accurate resident assessment documentation.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.